Metastatic Soft Tissue Sarcoma Completed Phase 3 Trials for Ridaforolimus (DB06233)

Also known as: Metastatic Soft-tissue Sarcoma / Metastatic Soft-Tissue Sarcomas

IndicationStatusPhase
DBCOND0055864 (Metastatic Soft Tissue Sarcoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00538239Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)Treatment